Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

KORU Medical Systems, Inc. Director's Dealing 2018

Oct 2, 2018

33778_dirs_2018-10-02_5def0519-ea02-4e14-b38e-44aa509ca3ff.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPRO MED SYSTEMS INC (REPR)
CIK: 0000704440
Period of Report: 2018-09-28

Reporting Person: Anderson David W (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-09-28 Common Stock A 1894 $1.65 Acquired 23824 Direct